Molecular Partners AG

NASDAQ: MOLN · Real-Time Price · USD
3.45
-0.07 (-1.99%)
At close: Aug 15, 2025, 3:43 PM
3.53
2.27%
After-hours: Aug 15, 2025, 04:04 PM EDT

Molecular Partners Income Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 681K 1.55M 2.74M 1.03M 2.54M 415K 3.05M 2.69M 2.34M 11.75M 172.78M 1.77M 3.53M 3.21M 815K
Cost of Revenue
n/a n/a n/a 13.09M 14.1M 11.91M 11.61M 11.63M 12.7M 12.21M 11.5M 12.57M 14.47M 12.46M 11.68M 15.42M 16.16M
Gross Profit
n/a n/a -10.18M -11.54M -11.37M -10.88M -9.07M -11.22M -9.64M -9.52M -9.16M -823K 158.31M -10.68M -8.15M -12.21M -15.35M
Operating Income
-16.14M -14.79M -14.59M -15.98M -15.86M -16.65M -13.49M -15.88M -15.09M -14.96M -14.69M -6.29M 152.55M -15.79M -12.84M -16.26M -18.53M
Interest Income
502K 651K 718K 912K 1.1M 1.13M 1.19M 1.09M 867K 644K 263.76K 161.62K 88K 42K 40K 10K 7K
Pretax Income
-16.77M -11.23M -16.4M -15.08M -11.32M -19.78M -11.44M -15.99M -14.78M -17.43M -13.32M -4.52M 153.13M -17.91M -12.31M -17.01M -16.55M
Net Income
-16.77M -11.23M -16.4M -15.08M -11.32M -19.78M -11.44M -15.99M -15.32M -20.54M -12.09M -2.67M 153.13M -17.91M -12.31M -17.01M -16.55M
Selling & General & Admin
4.22M 3.83M 4.41M 3.84M 3.89M 4.23M 4.42M 4.67M 5.44M 5.03M 5.56M 5.48M 5.76M 4.59M 4.69M 4.29M 3.34M
Research & Development
11.92M 10.55M 10.86M 13.09M 14.1M 12.85M 11.61M 11.63M 12.7M 12.21M 11.5M 12.57M 14.47M 12.46M 11.68M 15.42M 16.16M
Other Expenses
n/a 419K n/a -13.09M n/a n/a n/a n/a n/a 413K -27K -9K -5K 520K -6K -227K -162K
Operating Expenses
16.14M 14.79M 15.27M 16.92M 17.99M 17.08M 16.03M 16.3M 18.14M 17.65M 17.03M 18.04M 20.22M 17.56M 16.36M 19.48M 19.34M
Interest Expense
5K 6K 9K 6K 7K 11K 8K 9K 9K 8K 121.02K 249.68K 247K 104K 129K 140K 175K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
16.14M 14.79M 15.27M 17.53M 18.6M 17.68M 16.03M 16.3M 18.14M 17.65M 17.03M 18.04M 20.22M 17.56M 16.36M 19.48M 19.34M
Income Tax Expense
-2K 2K n/a n/a n/a n/a 8K 9K 545K 3.11M -1.23M -1.86M -735K 2K n/a n/a n/a
Shares Outstanding (Basic)
36.87M 34.03M 33.19M 33.18M 32.87M 32.85M 32.84M 32.83M 32.56M 36.04M 32.49M 32.5M 32.32M 23.61M 32.28M 30.26M 29.04M
Shares Outstanding (Diluted)
36.87M 34.03M 33.19M 33.18M 32.87M 32.85M 32.84M 32.83M 32.56M 36.04M 32.51M 33.14M 33.14M 23.61M 32.28M 30.72M 29.15M
EPS (Basic)
-0.45 -0.33 -0.49 -0.45 -0.34 -0.6 -0.35 -0.49 -0.47 -0.57 -0.37 -0.08 4.74 -0.76 -0.38 -0.56 -0.57
EPS (Diluted)
-0.45 -0.33 -0.49 -0.45 -0.34 -0.6 -0.35 -0.49 -0.47 -0.57 -0.37 -0.08 4.62 -0.76 -0.38 -0.55 -0.57
EBITDA
-16.21M -10.65M -15.8M -14.47M -10.71M -19.17M -10.82M -15.37M -14.16M -16.82M -12.62M -3.7M 153.18M -17.18M -11.55M -16.21M -15.72M
EBIT
-16.77M -11.22M -16.4M -15.07M -11.31M -19.77M -11.43M -15.97M -14.77M -17.42M -13.21M -4.28M 153.37M -17.8M -12.18M -16.87M -16.38M
Depreciation & Amortization
552K 570K 591K 603K 605K 602K 604K 604K 610K 599K 584K 582K 623K 626K 623K 656K 660K